» » Money and AducanumabHealthy Care Renewal
Edit

Money and AducanumabHealthy Care Renewal

In my previous posts, I haven't talked too much about the price set for aducanumab. Since I think it should not have been approved on current evidence regardless of price, the approval has been my focus. But of course the price is an issue, especially given that there is a HUGE pool of potential patients and that most are probably Medicare age, meaning that this drug can have huge impacts on

from Health Care Renewal https://ift.tt/3zsVDmb Money and AducanumabHealthy Care Renewal

Subscribe to receive free email updates:

0 Response to "Money and AducanumabHealthy Care Renewal"

Post a Comment

Subscribe to: Post Comments (Atom)